These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2161407)

  • 1. Combined modality radioprotection: the use of glucan and selenium with WR-2721.
    Patchen ML; MacVittie TJ; Weiss JF
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1069-75. PubMed ID: 2161407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postirradiation glucan administration enhances the radioprotective effects of WR-2721.
    Patchen ML; MacVittie TJ; Jackson WE
    Radiat Res; 1989 Jan; 117(1):59-69. PubMed ID: 2536480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioprotection by polysaccharides alone and in combination with aminothiols.
    Patchen ML; MacVittie TJ; Solberg BD; D'Alesandro MM; Brook I
    Adv Space Res; 1992; 12(2-3):233-48. PubMed ID: 11537014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival.
    Patchen ML; MacVittie TJ; Souza LM
    Int J Radiat Oncol Biol Phys; 1992; 22(4):773-9. PubMed ID: 1371988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug combination against single drug treatment in radiation protection of the bone marrow CFU.
    Bisht KS; Uma Devi P; Jagetia GC; Kamath G
    Strahlenther Onkol; 1990 Aug; 166(8):545-8. PubMed ID: 2168583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor.
    Patchen ML; MacVittie TJ; Solberg BD; Souza LM
    Exp Hematol; 1990 Oct; 18(9):1042-8. PubMed ID: 1697806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice.
    Patchen ML; MacVittie TJ
    Int J Immunopharmacol; 1985; 7(6):923-32. PubMed ID: 4077349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic effects of soluble glucan and WR-2721, independently and combined in C3H/HeN mice.
    Baker WH; Nold JB; Patchen ML; Jackson WE
    Proc Soc Exp Biol Med; 1992 Nov; 201(2):180-91. PubMed ID: 1329111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan.
    Patchen ML; MacVittie TJ
    Immunopharmacology; 1983 Apr; 5(4):303-13. PubMed ID: 6853144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemopoietic effects of intravenous soluble glucan administration.
    Patchen ML; MacVittie TJ
    J Immunopharmacol; 1986; 8(3):407-25. PubMed ID: 3760593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotective effects of WR-2721, Broncho-Vaxom and their combinations: survival, myelopoietic restoration and induction of colony-stimulating activity in mice.
    Fedorocko P; Brezáni P; Macková NO
    Int J Immunopharmacol; 1994 Feb; 16(2):177-84. PubMed ID: 8181906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment.
    Patchen ML; MacVittie TJ
    Acta Haematol; 1983; 70(5):281-8. PubMed ID: 6414220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327.
    Landauer MR; Castro CA; Benson KA; Hogan JB; Weiss JF
    J Appl Toxicol; 2001; 21(1):25-31. PubMed ID: 11180277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor and amifostine (Ethyol) synergize to enhance hemopoietic reconstitution and increase survival in irradiated animals.
    Patchen ML; MacVittie TJ
    Semin Oncol; 1994 Oct; 21(5 Suppl 11):26-32. PubMed ID: 7526469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioprotection by vitamin E: injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice.
    Srinivasan V; Weiss JF
    Int J Radiat Oncol Biol Phys; 1992; 23(4):841-5. PubMed ID: 1319980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721.
    Weiss JF; Hoover RL; Kumar KS
    Free Radic Res Commun; 1987; 3(1-5):33-8. PubMed ID: 2854528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
    Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
    Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of soluble and particulate glucans on survival in irradiated mice.
    Patchen ML; MacVittie TJ
    J Biol Response Mod; 1986 Feb; 5(1):45-60. PubMed ID: 3958754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage.
    Liu W; Chen Q; Wu S; Xia X; Wu A; Cui F; Gu YP; Zhang X; Cao J
    J Radiat Res; 2015 Mar; 56(2):278-86. PubMed ID: 25617317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.